Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab

被引：0

作者：

Parisi, Rose ^{[1
]}

Cowen, Emily A. ^{[1
]}

Gu, Stephanie ^{[1
]}

Dusza, Stephen ^{[1
]}

Pulitzer, Melissa ^{[2
,3
,4
]}

Geyer, Mark B. ^{[5
]}

King, Amber C. ^{[6
]}

Markova, Alina ^{[1
,4
,7
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, Dermatopathol Serv, New York, NY USA

[3] Mem Sloan kettering Canc Ctr, Dermatopathol Serv, Lab Med, New York, NY USA

[4] Cornell Univ, Weill Cornell Med Coll, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Dept Pharm, Clin Serv, Leukemia Serv, New York, NY USA

[7] 545 73rd St, New York, NY 10021 USA

来源：

LEUKEMIA & LYMPHOMA | 2023年

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA;

D O I：

10.1080/10428194.2023.2221756

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 11 条

[1]

[Anonymous], 2018, 4241595 FOOD DRUG AD

[2] Blinatumomab for Minimal Residual Disease (MRD) in Adults with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Median Overall Survival (OS) Is Not Reached in Complete MRD Responders at a Median Follow-up of 53.1 Months [J].

Goekbuget, Nicola ;

Dombret, Herve ;

Zugmaier, Gerhard ;

Bonifacio, Massimiliano ;

Graux, Carlos ;

Faul, Christoph ;

Topp, Max S. ;

Brueggemann, Monika ;

Taylor, Kate ;

Bargou, Ralf .

BLOOD, 2018, 132

[3] Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia [J].

Kantarjian, Hagop ;

Stein, Anthony ;

Goekbuget, Nicola ;

Fielding, Adele K. ;

Schuh, Andre C. ;

Ribera, Josep-Maria ;

Wei, Andrew ;

Dombret, Herve ;

Foa, Robin ;

Bassan, Renato ;

Arslan, Onder ;

Sanz, Miguel A. ;

Bergeron, Julie ;

Demirkan, Fatih ;

Lech-Maranda, Ewa ;

Rambaldi, Alessandro ;

Thomas, Xavier ;

Horst, Heinz-August ;

Brueggemann, Monika ;

Klapper, Wolfram ;

Wood, Brent L. ;

Fleishman, Alex ;

Nagorsen, Dirk ;

Holland, Christopher ;

Zimmerman, Zachary ;

Topp, Max S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09) :836-847

[4] Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab [J].

Klinger, Matthias ;

Brandl, Christian ;

Zugmaier, Gerhard ;

Hijazi, Youssef ;

Bargou, Ralf C. ;

Topp, Max S. ;

Goekbuget, Nicola ;

Neumann, Svenja ;

Goebeler, Mariele ;

Viardot, Andreas ;

Stelljes, Matthias ;

Brueggemann, Monika ;

Hoelzer, Dieter ;

Degenhard, Evelyn ;

Nagorsen, Dirk ;

Baeuerle, Patrick A. ;

Wolf, Andreas ;

Kufer, Peter .

BLOOD, 2012, 119 (26) :6226-6233

[5] Skin problems and EGFR-tyrosine kinase inhibitor [J].

Kozuki, Toshiyuki .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (04) :291-298

[6] Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review [J].

Leporini, Christian ;

Saullo, Francesca ;

Filippelli, Gianfranco ;

Sorrentino, Antonio ;

Lucia, Maria ;

Perri, Gino ;

La Gattuta, Gaetana ;

Infusino, Stefania ;

Toscano, Rosa ;

Dima, Gianluca ;

Olivito, Virginia ;

Paletta, Laura ;

Bottoni, Ugo ;

De Sarro, Giovambattista .

JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (05) :S78-S85

[7] Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study [J].

Martinelli, Giovanni ;

Boissel, Nicolas ;

Chevallier, Patrice ;

Ottmann, Oliver ;

Goekbuget, Nicola ;

Topp, Max S. ;

Fielding, Adele K. ;

Rambaldi, Alessandro ;

Ritchie, Ellen K. ;

Papayannidis, Cristina ;

Sterling, Lulu Ren ;

Benjamin, Jonathan ;

Stein, Anthony .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) :1795-+

[8]

MSKCCDT, 2023, DAT MED24582

[9] FDA Approval: Blinatumomab [J].

Przepiorka, Donna ;

Ko, Chia-Wen ;

Deisseroth, Albert ;

Yancey, Carolyn L. ;

Candau-Chacon, Reyes ;

Chiu, Haw-Jyh ;

Gehrke, Brenda J. ;

Gomez-Broughton, Candace ;

Kane, Robert C. ;

Kirshner, Susan ;

Mehrotra, Nitin ;

Ricks, Tiffany K. ;

Schmiel, Deborah ;

Song, Pengfei ;

Zhao, Ping ;

Zhou, Qing ;

Farrell, Ann T. ;

Pazdur, Richard .

CLINICAL CANCER RESEARCH, 2015, 21 (18) :4035-4039

[10] FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia [J].

Pulte, E. Dianne ;

Vallejo, Jonathon ;

Przepiorka, Donna ;

Nie, Lei ;

Farrell, Ann T. ;

Goldberg, Kirsten B. ;

McKee, Amy E. ;

Pazdur, Richard .

ONCOLOGIST, 2018, 23 (11) :1366-1371

← 1 2 →